Evaluating the population measles susceptibility in Tianjin, China. Issue 31 (26th June 2020)

• Record Type: Journal Article
• Authors: Ding, Yaxing; Chen, Wei; Lei, Yue; Mao, Naiying; Gao, Zhigang; Xu, Wenbo; Zhang, Ying
• Is Part Of: Vaccine. Volume 38:Issue 31(2020)
• Page Start: 4829
• Page End: 4836
• Publication Date: 2020-06-26
• Subjects: Measles -- China -- Seroprevalence -- IgG avidity -- Secondary vaccination failures; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.05.053
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Background: Measles is a highly infectious illness requiring herd immunity of 95% to interrupt transmission. China has not reached elimination goals despite high vaccination coverage. We estimated the population susceptibility against measles in Tianjin, China and to tailor awareness raising activities in the measles elimination plan. Methods: Age-specific measles seroprevalence was evaluated by Enzyme-Linked Immunosorbent Assay (ELISA) on 12, 164 individual aged 0–44 years in 2009–2018. Measles IgG avidity testing was performed to confirm the relationship of the waning immunity after vaccination and secondary vaccination failures (SVF) on 324 confirmed measles cases in 2013–2018. Results: 11, 108 samples (91.32%) tested positive for measles IgG, 239 (1.96%) tested as equivocal and 817 (6.72%) were negative. The age distribution of measles cases in Tianjin followed a U-shaped curve and was highest for those at <8 months and again at 20–39 years which correlated closely with the age distribution of measles susceptibility based on measles IgG antibody status ( r = 0.72, P < 0.001). The seropositivity rate and antibody geometric mean concentration (GMC) for the 2018 study population were significantly lower ( χ 2 = 7.45, P = 0.006 and t = 12.01, P < 0.001) compared to 2009. The multivariate stepwise logistic regression analysis showed that age and region were the risk factors for both measles seropositivity rate and GMC after vaccination. The proportion of high avidity cases increased with age, being significantly higher in 75.31% of cases in patients aged 30–34 years ( χ 2 = 18.04, P = 0.003). Conclusions: High immunization coverage in children alone will not be adequate to realizing sufficient levels of population herd immunity, particularly given that the potential susceptibility window in adult. Implementation of supplemental immunization activity (SIA) targeted to appropriate group aged 30–34 years is recommended.